Dr Claudio Ruffman discusses his research into the protein, Alpha-Synuclein, which is crucial in the pathogenesis of Parkinson's

Drug and Target Discovery in Parkinson's Disease

The OPDC Scientists and Clinicians talk about how their work is helping to improve the understanding of Parkinson's and drive us closer to a cure during the Oxford Parkinson's Disease Centre Participant Open Day, 18th March 2015.